%20Ver-2.png)
Many serious diseases are driven by cells located outside the liver, in tissues and organs that remain largely inaccessible to existing delivery technologies.
RAPTOR™ was built to overcome this barrier by learning which delivery strategies actually work in living biology
The RAPTOR™ Platform
Our RAPTOR™ platform is a scalable discovery system that identifies delivery solutions that work inside the human body. By learning from and working with the existing biology, RAPTOR enables genetic payloads to reach specific cell populations that have historically been inaccessible.
Our initial focus has been the bone marrow—a complex, disease-relevant environment central to both hematologic cancers and autoimmune disease.
A Focus on Biological Domains
RAPTOR was designed to explore and expand the delivery of genetic medicines throughout the body. Our initial work has focused on immune cells and the bone marrow—therapeutically rich biological domains containing multiple disease-driving cell populations and historically resistant to genetic delivery.
Success in this environment enables treatment of bone-marrow–driven diseases today, while informing future opportunities in additional tissues.
Turning Delivery Into Treatment
By solving the delivery problem, RAPTOR translates genetic payloads into therapeutic action. Liberate’s first programs demonstrate this capability through direct, in vivo reprogramming of immune cells, without ex vivo manipulation.
